Results 51 to 60 of about 45,910 (249)

Resolution in bullous pemphigoid [PDF]

Seminars in Immunopathology, 2019
AbstractPemphigoid diseases are a group of autoimmune blistering skin diseases defined by an immune response against certain components of the dermal-epidermal adhesion complex. They are prototypical, autoantibody-driven, organ-specific diseases with the emergence of inflammatory skin lesions dependent on the recruitment of immune cells, particularly ...
Christian D. Sadik, Enno Schmidt
openaire   +3 more sources

Regression of cutaneous squamous cell carcinoma after the development of pembrolizumab‐induced bullous pemphigoid

JEADV Clinical Practice, 2023
Bullous pemphigoid is a rare complication of immune checkpoint inhibitor treatment. We report a case of pembrolizumab‐induced bullous pemphigoid in a patient with malignant melanoma and concomitant cutaneous squamous cell carcinoma that regressed.
Shin Iinuma, Kei Hayashi, Akemi Ishida‐Yamamoto   +2 more
doaj   +1 more source

Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic non-inferiority randomised controlled trial [PDF]

, 2017
Background: Bullous pemphigoid (BP) is a blistering skin disorder with increased mortality. We tested whether a strategy of starting treatment with doxycycline conveys acceptable short-term blister control whilst conferring long-term safety advantages ...
A Anstey, A Carmichael, A Lloyd Lavery, A M Layton, A Omerod, Adam Ferguson, Adzura Azam, Alex Waters, Andrew Ilchyshyn, Andrew J Nunn, Andrew Wright, Anna Chapman, B Walker, Bastuji-Garin, Bratton, Brick, C Barnard, C Günthert, C Thomas, Chalmers, Chalmers, Chris Bower, Chris Lovell, D'Agostino, David Gawkrodger, Diane Whitham, E Bröcker, E Veysey, Emilia Duarte-Williamson, Enno Schmidt, F Craig, Feliciani, Fenella Wojnarowska, Fiona Antony, Fivenson, G Patel, G Wong, Goon, Gudula Kirtschig, H Bell, H Malhomme, H Santander, Hofmann, Hywel C Williams, Indre Verpetinske, Ingrid Salvary, J Adams, J English, J Ingram, J Ravenscroft, J Wee, James Mason, Jane Sterling, Joanne R Chalmers, Joly, Joly, Joly, K Davies, K Hussain, K Steinbrink, Karen Gibbon, Karen Harman, Kathy Taghipour, Kirtschig, Langan, Lever, Lloyd-Lavery, M G S Dunnill, M Sticherling, M Vatve, M Walsh, M Westmoreland, Margaret Childs, Marinella Nik, Meijer, Monk, Murrell, N Hepburn, N J Levell, N van Beek, Offen, P J Hampton, R Ellis, R Gläser, R Groves, R Hügel, R R Coelho, R Rallan, R Wachsmuth, Riond, Robert Charles-Holmes, Roujeau, S Blackford, S Wahie, Sam Gibbs, Savin, Schmidt, Schulze, Shernaz Walton, Sobocinski, Taghipour, Taghipour, Thomas Luger, Thomas R Godec, V Akhras, V Lewis, V Venning, Venning, Walter Bottomley   +108 more
core   +4 more sources

Bullous Pemphygoid and Novel Therapeutic Approaches

Biomedicines, 2022
Bullous pemphigoid is a subepidermal blistering disease associated with autoantibodies (auto-ab) to BP180 and BP230 which affects elderly patients, predominately.
Giovanni Marco D’Agostino, Giulio Rizzetto, Andrea Marani, Samuele Marasca, Matteo Candelora, Daisy Gambini, Helena Gioacchini, Edoardo De Simoni, Andrea Maurizi, Anna Campanati, Annamaria Offidani   +10 more
doaj   +1 more source

Successful treatment of bullous pemphigoid with dupilumab: a case and brief review of the literature.

Dermatology Online Journal, 2021
Bullous pemphigoid is an autoimmune skin disease that results in formation of pruritic blisters. Most cases are treated with a combination of systemic and topical corticosteroids as well as other immunomodulatory drugs.
M. Saleh, Matthew Reedy, H. Torok, J. Weaver   +3 more
semanticscholar   +1 more source

The impact of lesional inflammatory cellular infiltrate on the phenotype of bullous pemphigoid

Journal of the European Academy of Dermatology and Venereology, 2021
The influence of cutaneous cellular infiltration on the phenotype of bullous pemphigoid (BP) remains to be established.
S. Ständer, C. Hammers, A. Vorobyev, E. Schmidt, D. Zillikens, S. Ghorbanalipoor, K. Bieber, R. Ludwig, K. Kridin   +8 more
semanticscholar   +1 more source

Correlation between bullous pemphigoid and type 2 inflammation

Pifu-xingbing zhenliaoxue zazhi, 2022
Bullous pemphigoid (BP) is one of the common autoimmune blister diseases that mainly affects the elderly. Most bullous pemphigoid patients have obvious symptom of pruritus, accompanied by elevated levels of serum total IgE, peripheral blood eosinophils ...
Yao ZHOU, Guomin LI, Zhijun XU, Jie XU, Jinjin ZHENG, Hao FANG, Ruzeng XUE   +6 more
doaj   +1 more source

Eosinophilic dermatosis of hematologic malignancy: a case report [PDF]

, 2020
Eosinophilic dermatosis of hematologic malignancy (EDHM) is a dermatosis characterized by tissue eosinophilia that has been previously reported as insect bite-like reaction.
Almeida, FT, Brito, C, Caldas, R, Ferreira, O, Rodrigues, AP   +4 more
core  

Bullous pemphigoid in infants: characteristics, diagnosis and treatment [PDF]

, 2014
BACKGROUND: Bullous pemphigoid (BP) in infants is a rare but increasingly reported autoimmune blistering skin disease. Autoantibody reactivity is usually poorly characterized. Current guidelines do not address specific aspects of the infantile form of BP.
Agnes Schwieger-Briel, Birgit Mattulat, Cassian Sitaru, Cornelia Moellmann, Dimitra Kiritsi, Enno Schmidt, Franziska Schauer, Hagen Ott, Johannes S Kern   +8 more
core   +2 more sources

New-Onset Bullous Pemphigoid in a COVID-19 Patient

Case Reports in Dermatological Medicine, 2021
This manuscript presents a report of bullous pemphigoid rash associated with COVID-19 for the first time. The objective of this manuscript is to present a unique dermatological case in the setting of a COVID-19-positive infection to further recognize the
N. Olson, David Eckhardt, Angela Delano
semanticscholar   +1 more source